Repare Therapeutics Inc. Stock
Stocks
RPTX
US7602731025
Biotechnology & Medical Research
|
Delayed
Nasdaq
16:00:00 2026-01-27 EST
|
5-day change | 1st Jan Change | ||
| 2.650 USD | +0.76% |
|
-.--% | +1.92% |
| 02-03 | Pyxis Oncology, Inc. Announces Chief Executive Officer Changes, Effective February 3, 2026 | CI |
| 01-27 | Repare Therapeutics Inc.(NasdaqGS:RPTX) dropped from NASDAQ Composite Index | CI |
| Market Cap | 112M 98.91M 93.59M 84.87M 159M 10.75B 161M 1.12B 433M 5.49B 421M 412M 17.67B | P/E 2023 |
-3.28x | P/E 2024 | -0.66x |
|---|---|---|---|---|---|
| Enterprise Value | -38.78M -34.22M -32.38M -29.36M -55.05M -3.72B -55.59M -388M -150M -1.9B -146M -142M -6.11B | EV / Sales 2023 |
1,707,888x | EV / Sales 2024 | -1,779,624x |
| Free-Float |
99.77% | Yield 2023 * |
-
| Yield 2024 | - |
| 1 day | +0.76% | ||
| Current year | +1.92% |
| Current year | 2.5 |  | 2.65 |
| 1 year | 1.65 | | 2.66 |
| 3 years | 0.89 | | 12.16 |
| 5 years | 0.89 | | 28.24 |
| 10 years | 0.89 | | 46.44 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jon Adkins
PSD | President | - | 2026-01-27 |
| Director | Title | Age | Since |
|---|---|---|---|
Jon Adkins
BRD | Director/Board Member | - | 2026-01-27 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 1/28/26 | Issuer sale | Chief Executive Officer | 1,167,586 | 2.7085% | ||
| 1/28/26 | BVF Partners LP
| Tender | Company | 10,166,943 | 23.5846% | |
| 1/28/26 | Issuer sale | Chairman | 7,500 | 0.0174% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.76% | -.--% | +52.30% | -78.06% | 114M | |
| -0.03% | +3.77% | +12.35% | +37.22% | 48.85B | |
| -0.73% | -0.41% | +48.84% | +36.72% | 44.28B | |
| +1.36% | +6.03% | +343.85% | +638.73% | 43.83B | |
| -0.47% | -0.76% | +9.75% | +103.07% | 41.53B | |
| +0.34% | +0.22% | +5.18% | +47.36% | 30.13B | |
| +1.00% | -1.28% | +24.23% | +156.93% | 17.36B | |
| -3.20% | -3.50% | +25.33% | +42.43% | 14.99B | |
| -2.94% | +6.98% | +5.10% | - | 14.9B | |
| -0.86% | -4.00% | - | - | 14.98B | |
| Average | -0.48% | +0.55% | +58.55% | +123.05% | 27.1B | |
| Weighted average by Cap. | -0.26% | +1.21% | +75.31% | +167.98% |
| 2023 | 2024 | |
|---|---|---|
| Net sales | 51.13 45.12 42.7 38.72 72.59 4.91K 73.31 512.19 197.4 2.51K 192 187.83 8.06K | 53.48 47.19 44.65 40.49 75.92 5.13K 76.67 535.66 206.45 2.62K 200.81 196.44 8.43K |
| Net income | -93.8M -82.77M -78.32M -71.03M -133M -9B -134M -940M -362M -4.6B -352M -345M -14.79B | -84.69M -74.74M -70.71M -64.13M -120M -8.13B -121M -848M -327M -4.15B -318M -311M -13.35B |
| Net Debt | -220M -194M -184M -167M -313M -21.13B -316M -2.21B -850M -10.79B -827M -809M -34.72B | -151M -133M -126M -114M -214M -14.48B -216M -1.51B -582M -7.39B -566M -554M -23.79B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- RPTX Stock
Select your edition
All financial news and data tailored to specific country editions
